Evidence map›Paper›PMID 30660052›Full record

ArticleBiomaterials2019

Creating a capture zone in microfluidic flow greatly enhances the throughput and efficiency of cancer detection.

Mingrui Sun, Jiangsheng Xu, James G Shamul, Xiongbin Lu, Syed Husain, Xiaoming He

Abstract read
In one paragraph

Article in Biomaterials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Application of Microfluidics in Detection of Circulating Tumor Cells.Frontiers in bioengineering and biotechnology · 2022
    Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mingrui SunDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH 43210, USA.
Jiangsheng XuDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH 43210, USA; Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA; Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
James G ShamulFischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA.
Xiongbin LuDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Syed HusainComprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA; Department of Surgery, The Ohio State University Medical Center, Columbus, OH 43210, USA.
Xiaoming HeDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH 43210, USA; Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA; Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA; Robert E. Fischell Institute for Biomedical Devices, University of Maryland, College Park, MD 20742, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD 21201, USA. Electronic address: shawnhe@umd.edu.

Funding

Nanotechnology enabled targeting of p53 deficiency in human cancerR01CA206366 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI HE, XIAOMING, LU, XIONGBIN · 2016 to 2020
$1.9M
NCI NIH HHS R01 CA206366
6 · The paper itself

Abstract

Efficient capture of rare circulating tumor cells (CTCs) from blood samples is valuable for early cancer detection to improve the management of cancer. In this work, we developed a highly efficient microfluidics-based method for detecting CTCs in human blood. This is achieved by creating separate capture and flow zones in the microfluidic device (ZonesChip) and using patterned dielectrophoretic force to direct cells from the flow zone into the capture zone. This separation of the capture and flow zones minimizes the negative impact of high flow speed (and thus high throughput) and force in the flow zone on the capture efficiency, overcoming a major bottleneck of contemporary microfluidic approaches using overlapping flow and capture zones for CTC detection. When the flow speed is high (≥0.58 mm/s) in the flow zone, the separation of capture and flow zones in our ZonesChip could improve the capture efficiency from ∼0% (for conventional device without separating the two zones) to ∼100%. Our ZonesChip shows great promise as an effective platform for the detection of CTCs in blood from patients with early/localized-stage colorectal tumors.

Indexed as

Cell Line, TumorCell SeparationColorectal NeoplasmsEarly Detection of CancerEquipment DesignHumansMicrofluidic Analytical TechniquesNeoplasmsNeoplastic Cells, CirculatingCapture zoneCTCsDetectionDielectrophesisFlow zoneMicrofluidics

Identifiers

PMID30660052
PMCPMC6402573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.